Jounce Therapeutics Inc (JNCE)

NASDAQ
7.07
-0.30(-4.07%)
After Hours
7.04
-0.03(-0.42%)
- Real-time Data
  • Volume:
    495,434
  • Bid/Ask:
    7.04/7.29
  • Day's Range:
    6.78 - 7.15

JNCE Overview

Prev. Close
7.37
Day's Range
6.78-7.15
Revenue
63.88M
Open
7.09
52 wk Range
4.43-14.81
EPS
-1.23
Volume
495,434
Market Cap
362.04M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
340,345
P/E Ratio
-
Beta
1.12
1-Year Change
30.93%
Shares Outstanding
51,208,357
Next Earnings Date
Aug 11, 2021
What is your sentiment on Jounce Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Jounce Therapeutics Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralNeutralSellStrong SellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong SellStrong SellSell
SummaryBuyBuyStrong SellStrong SellStrong Sell

Jounce Therapeutics Inc Company Profile

Jounce Therapeutics Inc Company Profile

Employees
128

Jounce Therapeutics, Inc. is a clinical stage immunotherapy company. The Company is engaged in transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long lasting benefits to patients. Through the use of its Translational Science Platform, Jounce first focuses on specific cell types within tumors to prioritize targets, and then identifies related biomarkers designed to match the right therapy to the right patient. The Company’s lead product candidate, JTX-2011, is a monoclonal antibody that binds to and activates Inducible T cell CO-Stimulator (ICOS) and is in a Phase II trial.

Read More
  • I was ready to dump this stock and was waiting for the 7.45 range so I can break even since May timeline...I never expected the good news today.. this will explode with big pharma investors...I was pleasantly surprised today with this news. this originally had a target price of 9.50 and it should be a good investment for 2021..so hold on for the ride! ..
    0
    • Worth 0.8B
      0
      • Gilead signs with Jnce and will pay $35m upfront in shares and later up to $685m royalties, great news for Jnce
        0
        • hello ! somebody have any new regarding JNCE, will it go up soon?
          0
          • target: $15
            0
            • Short this ?
              1
              Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
              Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.